| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $54.7M | -10.2% |
| Cost of Revenue | $47.0M | +9.4% |
| Gross Profit | $7.7M | -57.0% |
| R&D Expense | $4.1M | -5.4% |
| SG&A Expense | $9.0M | -3.2% |
| Operating Income | -$13.4M | -68.6% |
| Interest Expense | $74K | -37.1% |
| Pre-tax Income | -$12.9M | -123.0% |
| Income Tax | $727K |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.8M | +67.8% |
| Short-term Investments | $3.2M | -58.6% |
| Accounts Receivable | $8.2M | -1.7% |
| Inventory | $13.2M | -39.3% |
| Current Assets | $32.2M | -24.1% |
| Total Assets | $36.9M | -23.5% |
| Current Liabilities | $8.2M | +19.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$108K | +75.4% |
| Capital Expenditures | $363K | -55.9% |
| Investing Cash Flow | $4.2M | +175.6% |
| Financing Cash Flow | -$1.2M | -591.0% |
| Free Cash Flow | -$471K | +62.7% |
| -21.6% |
| Net Income | -$13.6M | -103.0% |
| EPS (Basic) | -$0.65 | -103.1% |
| EPS (Diluted) | -$0.65 | -103.1% |
| Total Liabilities |
| $9.8M |
| +12.4% |
| Stockholders' Equity | $27.2M | -31.4% |